🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-522731-34-00
Completed Phase I

A trial to learn how safe AZD5335 is and if a drug called itraconazole changes how AZD5335 moves through the body over time in adults with ovarian, peritoneal, or fallopian tube cancer

2025-522731-34-00 · tracked via the Priya Life Science EU tracker
Sponsor
AstraZeneca AB
Sponsor type
Pharmaceutical company
Therapeutic area
Neoplasms
Decision date
15/01/2026
Enrollment target
34
Sites
Spain, Ireland, Portugal

Condition studied

Ovarian cancer Primary peritoneal cancer Fallopian tube cancer

Eligibility

Age group
18-64 years, 65+ years
Sex
Female
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-522731-34-00 on CTIS ↗ ← All trials in the EU